NCT05714202 · Interventional trial
A Study of TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guérin (BCG) in Participants With BCG-naïve High-risk Non-muscle Invasive Bladder Cancer (HR-NMIBC)
Overall registry status Active not recruiting
Phase 3
Conditions Bladder Cancer
Delaware Valley sites
- Centers for Advanced Urology LLC d b a MidLantic Urology · Bala-Cynwyd, PA · Montgomery County
- Cooper Health System MD Anderson Cancer Center at Cooper · Camden, NJ · Camden County
- Thomas Jefferson University Hospital · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory